TI
OPNT

Trexquant Investment’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Trexquant Investment’s Portfolio OPNT Stock Details OPNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-13,219
Closed -$142K – 1838
2022
Q3 		$142K Buy
13,219
+1,000
+8% +$11.3K 0.01% 1250
2022
Q2 		$147K Buy
12,219
+206
+2% +$3.32K 0.01% 1408
2022
Q1 		$257K Buy
+12,013
New +$318K 0.01% 1084

Other funds holding OPNT

WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
ACA
Apis Capital Advisors New York $648M AUM 302.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
NYLIM
New York Life Investment Management New York $11.8B AUM 23.45% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
RA
Ramius Advisors New York $95.2M AUM 7.33% 1-Year Est. Return

Trexquant Investment's OPNT Position: Q4 2022 in Review

Trexquant Investment sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q4 2022, closing a stake of 13,219 shares — an estimated $142K sold.

Trexquant Investment first reported a position in OPNT in Q1 2022 and held it in 3 quarters. The position peaked at $257K in Q1 2022. 37 funds tracked by Wall St. Rank hold OPNT as of Q4 2022.

  • Trexquant Investment reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Trexquant Investment sold 13,219 Opiant Pharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $142K.
  • Trexquant Investment first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q1 2022 and held it in 3 quarters.
  • Trexquant Investment's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $257K in Q1 2022.
  • 37 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on Trexquant Investment's 13F filing for Q4 2022, filed 13 Feb 2023.